biotechnolog arri buy deep-div stat analysi support high convict head beacon interim
analysi remain best idea
woe continu updat estim ftr win news snap promot chief account interim
page analyst certif import disclosur
 end high note top line growth look
publish januari
messag deliv impress perform organ sale growth rise high despit challeng yoy
comp solid oper leverag drive ep beat manag expect year guidanc call ep
organ sale growth given compani current momentum see top half rang achiev
posit one best fundament stori sector rais pt reiter
buy rate
 mute rapastinel management feedback hard ignor lower
rapastinel sale
publish januari
messag follow describ lukewarm commentari rapastinel earn call lower
sale estim drug view depress agent must deliv highli differenti profil clearli
dont know reason ignor chang mgmt tone/languag regard transform potenti product togeth
chang overal model follow result lower pt maintain long-term buy rate
earn
publish januari
messag madison squar garden compani report earn februari compani host confer call
et confer id outlook manag commentari summari key thesi debat includ within
maintain buy rate msg believ propos spin-off sport busi link achiev better market valuat
compani nba nhl team asset support invest growth entertain
page analyst certif import disclosur
arri buy deep-div stat analysi support high
convict head beacon interim analysi
remain best idea
publish januari
messag upcom phase trial interim result arri lead product candid braftovi mektovi braf-mut posit metastat
colorect cancer repres major binari event stock note provid preview beacon interim analysi
context broader braf landscap provid detail statist analysi highlight potenti trial outcom base analysi
maintain high convict buy rate best idea statu stock continu believ stock attract valu estim
upsid year bull-cas scenario
publish januari
messag verizon post weaker expect wireless servic revenu provid ep guidanc lower consensu
expect wireless subscrib metric pre-announce servic revenu impact coupl item includ ca wildfir
would grown mid rang normal basi ep guidanc segment oper perform would driven
organ ep growth off-set interest tax headwind expect see upsid share move part
fulli digest
arpo buy scenario could result upsid phase
data read march
publish januari
messag phase result npdr patient expect march depend strength data seen believ arpo
could worth per share studi meet primari endpoint per share also show improv certain
secondari endpoint case failur calcul cash per share howev even would approxim per share
option associ success arpo partner embed arpo share underappreci
investor view
page analyst certif import disclosur
publish januari
messag remain upbeat prospect bring ebitda estim better reflect invest highlight
strong dec data point modest acceler hotel reserv volum hotel air trend leav us comfort slightli above-
street estim temper ebitda estim consid invest potenti re-ramp market
remain consensu modest valuat favor outlook low buysid expect continu see
 yield non -come traffic
publish januari
messag close report includ marketplac gmv growth yoy cc in-lin deceler qoq despit
heavi site invest advertis ep vs ebay plan refocu marketing/invest new
user slow spend overal expect hinder gmv growth come quarter encourag strong capit return program
announc today includ increas share repurchas program initi dividend remain neutral core marketplac gmv
buy result rais question
enough pipelin drive share
publish januari
messag ms revenu flat sequenti spinraza sale howev manag guid spinraza growth continu
estim no-pipelin valu per share coupl rel stabl top-lin share buyback expand pipelin
give us confid rate unargu alzheim diseas program data aducanumab expect remain highest
profil program howev emerg new drug candid likelihood busi develop could also support
page analyst certif import disclosur
publish januari
messag cielo report ep miss vs our/consensu higher-than-expect expens lower-than-expect
financi incom transact volum in-lin call manag highlight continu aggress price action sme segment
underneath hood cielo po base grew qoq posit sign l-t investor view est come greater profit margin
degrad previous anticip consequ tough competit environ bottom line risk/reward balanc remain
 buy like
publish januari
messag share sold today reaction compani project springboard updat market question lower irr eur per
ft ip resourc potenti springer wonder howev wrong black oil play capabl deliv irr oil
high oil cut drill over-pressur psi/ft less month spud-to-sal cycl time format water oil ga
water pipe market strong differenti
pack bag your go south american
publish januari
messag yesterday sempra announc initi sale process chilean peruvian util sale sa util
contempl sinc june analyst day fit well strateg vision becom north american infrastructur compani
like earn dilut transact ampl opportun keep transact valu neutral accret advanc strateg
vision creat valuat multipl expans
page analyst certif import disclosur
publish januari
messag morn cs buy announc posit top-lin result long-term phase studi tanezumab
mg mg patient moderate-to-sever osteoarthr oa pain safeti data fairli consist prior studi outstand
question efficaci window studi given narrow efficaci window seen phase data acr placebo appear
perform better earlier studi await detail efficaci result accord press releas present futur medic
publish januari
guggenheim ndr schedul pleas scroll
pack bag your go south american util sale process way see note
file bankruptci cite wildfir cost
cpuc approv bankruptci financ emerg vote session
california ca insur commission issu estim insur loss claim wildfir
offici request en banc review acp nation forest servic permit
es legisl call renew
pjm/miso/spp weather alert issu advanc polar vortex
ferc attorney gener sign effort seek mcname recus resili
ercot puct report paint tight pictur reserv margin
daili facebook inspir confid invest wirelin woe continu updat estim
ftr win news snap promot chief account interim cfo
page analyst certif import disclosur
publish januari
fb morri highlight key debat surround facebook includ instagram growth driver increment invest platform secur ahead
compani earn report
ftr win mccormack updat telco model lower target ftr win
page analyst certif import disclosur
inc
page analyst certif import disclosur
smart final store inc
page analyst certif import disclosur
explor product
page analyst certif import disclosur
page analyst certif import disclosur
